Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses
Clinical trial NCT01756950 · COMPLETED
Trial details
- NCT number
- NCT01756950
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2013-11-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.